文献速递瓣膜外科

德国国家质量数据库:孤立性主动脉瓣置换风险评分评估

Evaluation of Risk Score for Isolated Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement-Results from the German National Quality Database.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2026-01-01

基于德国2015至2020年强制性质量保证数据的回顾性队列研究,比较EuroSCORE II、AKL-Cath评分与AKL-Chir评分对孤立性外科主动脉瓣置换(SAVR)和经导管主动脉瓣植入(TAVI)患者院内死亡风险的预测准确性。结果显示EuroSCORE II高估TAVI风险、低估SAVR风险,而AKL-Cath评分对TAVI、AKL-Chir评分对SAVR的死亡风险估计良好。

要点

  • AKL-Chir评分对SAVR、AKL-Cath评分对TAVI的死亡风险预测优于EuroSCORE II。
  • EuroSCORE II高估TAVI死亡风险并低估SAVR死亡风险。
  • 2015至2020年德国孤立SAVR数量下降37.6%,TAVI数量增加37.3%。

核心结论

  • AKL-Chir评分和AKL-Cath评分比EuroSCORE II更精确地估计SAVR和TAVI患者的死亡风险。

研究设计与样本

  • 基于德国2015至2020年强制性质量保证数据的回顾性队列研究,分析全国所有接受治疗患者的院内死亡率。

主要发现

  • 孤立SAVR手术量从2015年9790例降至2020年6106例,降幅37.6%。
  • TAVI院内死亡率从2015年4%降至2020年2.5%,SAVR院内死亡率维持约3%。
  • EuroSCORE II高估TAVI风险并低估SAVR风险。
  • AKL-Cath评分良好估计TAVI组死亡风险,AKL-Chir评分良好估计SAVR组死亡风险。

关键数值与推荐

  • AKL-Chir评分在TAVI患者中高估死亡风险。
  • AKL-Cath评分在SAVR患者中低估死亡风险。

临床怎么用

  • 临床可用AKL-Chir评分评估SAVR患者死亡风险,用AKL-Cath评分评估TAVI患者死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: For the treatment of aortic valve stenoses, both surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) are available. We compared the frequently used Euroscore with the AKL-Cath- and the AKL-Chir Score, describing the mortality risk of the 2 different treatment methods. METHODS: Based on a retrospective cohort study using mandatory quality assurance data, we analysed the frequency and the outcomes (primary end-point: in-hospital mortality) of all patients treated in Germany between 2015 and 2020. The observed results were compared to the predicted risk using the Euroscore, the AKL-Cath Score, and the AKL-Chir Score. RESULTS: Our data show a reduction in the number of isolated SAVR procedures from 9790 in 2015 to 6106 in 2020, corresponding to a 37.6% decrease. Over the same period, the number of TAVI procedures increased from 15 653 to 21 501, an increase of 37.3%. Regarding in-hospital mortality following TAVI, there was a decline from 4% (2015) to 2.5% (2020), while in-hospital mortality following SAVR remained nearly constant at 3%. Over the study period, there is an overestimation of TAVI risk while simultaneously underestimating SAVR risk by EuroSCORE II. In contrast, the mortality risk of patients is well estimated using the AKL-Kath Score in the TAVI group and the AKL-Chir Score in the SAVR group. The AKL-Chir Score in TAVI patients overestimates their mortality, while the AKL-Kath Score underestimates the mortality of SAVR patients. CONCLUSIONS: AKL-Chir score and AKL-Cath score estimate the mortality risk of SAVR and TAVI patients more precisely than the Euroscore II.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Böning A, Beckmann A, Heinemann M, et al. Evaluation of Risk Score for Isolated Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement-Results from the German National Quality Database. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41428411. doi:10.1093/icvts/ivaf307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。